The Impact of Pregnancy Outcomes on Thalassemia Trait in Poor Bangladeshi Mothers

Authors

Dr. Moazzem Hossain

Chairman, Institute of Allergy and Clinical Immunology of Bangladesh (IACIB) and Director, Thalassemia Hospital and Institute (A Project under IACIB) Zinzira, Savar, Dhaka- 1341 (Bangladesh)

Dr. Shamima Nasrin Shadia

Assistant Professor, Department of Pathology, Gonoshasthaya Samaj Vittik Medical College, Mirzanagar, Savar, Dhaka (Bangladesh)

Dr. Sukalyan Kumar Kundu

Professor, Department of Pharmacy, Jahangirnagar University, Savar, Dhaka-1342 (Bangladesh)

Dr. Monira Islam Lima

Junior Consultant, Laboratory Medicine, Ashulia Women and Child Hospital, Ashulia, Dhaka (Bangladesh)

Dr. Sadia Afrin

Medical officer, Thalassemia Hospital and Institute Zinzira, Savar, Dhaka- 1341 (Bangladesh)

Article Information

DOI: 10.51244/IJRSI.2026.1315PH00093

Subject Category: Health Science

Volume/Issue: 13/15 | Page No: 2445-2452

Publication Timeline

Submitted: 2026-04-15

Accepted: 2026-04-20

Published: 2026-06-01

Abstract

Thalassemia is an inherited blood disorder. The pregnant mothers with thalassemia trait can causes severe to mild complications. The aim of our recent study was to find out the outcome of pregnant mothers with thalassemia trait. This is a prospective case control study in two Hospitals Gonoshasthaya Samaj Vittik Medical College, Savar and Thalassemia Hospital and Institute, Zinzira, Dhaka, Bangladesh. All pregnancies occurred between January 2022 to December 2024 were included. Study group (n =21) are Beta thalassemia trait and normal hemoglobin variants are included in Control group (n = 84). Data was analyzed by Microsoft Excel and Statistical Package for the Social Sciences (SPSS-25).
Beta Thalassemia trait mothers had mean hemoglobin (Hb) 9.2 gm/dl and required Blood transfusion 14% cases. In normal Hb Pattern mothers had mean hemoglobin 11.2gm/dl and Required Blood transfusion 2% cases. Other like Hb E trait and Hb D trait mothers had mean respectively Hb 10.2gm/dl and 10.7gm/dl Hb E trait and Hb D trait mothers required no blood transfusion in their pregnancy. There is a significant relationship between the control group and study group regarding anemia as well as other adverse maternal outcome like gestational hypertension and antepartum hemorrhage. The odds ratio (OR) gestational hypertension is 2.96 and antepartum hemorrhage is 4.15 which reflects study group has more chances of these adverse outcome. The odds ratio (OR) of gestational diabetes postpartum hemorrhage, postpartum depression and cesarean section were more than one (>1), it indicates study group have chance of mentioned adverse outcome. In the study group, the odds ratio (OR) is 0.49 is lower odds for normal vaginal delivery (NVD).
In fetal outcome higher odds are NICU admission, APGAR score <7 at 5 min, also still birth is a risk factor. There are no significant relation with pre term birth, macrosomia and APGAR score<7 at 1 min. The odds ratio (OR) IUGR and fetal weight <2.5kg are lower 0.83 and 0.87 respectively. The present study shows more anemia’s in asymptomatic mother who were beta thalassemia carrier. So thalassemia trait mother need special care during and after delivery. To reduce adverse pregnancy outcomes need nutritional supplementation, dietary modification and genetic counseling to the thalassemia trait mothers.

Keywords

Anemia, thalassemia trait, outcome, Pregnancy

Downloads

References

1. Obeagu GU, Obeagu EI. Complications of anemia in pregnancy: An updated overview for healthcare professionals. Medicine. 2025 Aug 29;104(35):e44246. [Google Scholar] [Crossref]

2. Chelysheva, D., Syed, A., Ruby, H., Homeniuk, A., Atrash, A., & Moussally, F. A. (2025). Pregnancy Outcomes in Women With Thalassemia Trait: A Multicenter Cohort Study. Anemia, 2025(1), 8899690. [Google Scholar] [Crossref]

3. Huffman JW. Pregnancy. Encyclopedia Britannica. 2023. https://www.britannica.com/science/pregnancy. [Google Scholar] [Crossref]

4. Soma-Pillay, P., Nelson-Piercy, C., Tolppanen, H., & Mebazaa, A. (2016). Physiological changes in pregnancy: review articles. Cardiovascular journal of Africa, 27(2), 89-94. [Google Scholar] [Crossref]

5. WHO. Aneamia Facts. 2019. [Google Scholar] [Crossref]

6. Jouanne, M., Oddoux, S., Noël, A., & Voisin-Chiret, A. S. (2021). Nutrient requirements during pregnancy and lactation. Nutrients, 13(2), 692. [Google Scholar] [Crossref]

7. Kazma, J. M., van den Anker, J., Allegaert, K., Dallmann, A., & Ahmadzia, H. K. (2020). Anatomical and physiological alterations of pregnancy. Journal of pharmacokinetics and pharmacodynamics, 47(4), 271-285. [Google Scholar] [Crossref]

8. Hytten, F. (1985). Blood volume changes in normal pregnancy. Clinics in haematology, 14(3), 601-612. [Google Scholar] [Crossref]

9. Aparicio, E., Jardí, C., Bedmar, C., Pallejà, M., Basora, J., Arija, V., & ECLIPSES Study Group. (2020). Nutrient intake during pregnancy and post-partum: ECLIPSES study. Nutrients, 12(5), 1325. [Google Scholar] [Crossref]

10. Klinken SP. Red blood cells. Int J Biochem Cell Biol. 2002;34:1513–8. [Google Scholar] [Crossref]

11. Pawloski, J. R., Hess, D. T., & Stamler, J. S. (2001). Export by red blood cells of nitric oxide bioactivity. Nature, 409(6820), 622-626. [Google Scholar] [Crossref]

12. Abu-Ouf, N. M., & Jan, M. M. (2015). The impact of maternal iron deficiency and iron deficiency anemia on child’s health. Saudi medical journal, 36(2), 146. [Google Scholar] [Crossref]

13. Mahmood, S. A., Khalaf, A. A., & Hamadi, S. S. (2025). Basrah score: a novel machine learning-based score for differentiating iron deficiency anemia and beta thalassemia trait using RBC indices. Frontiers in Big Data, 8, 1634133. [Google Scholar] [Crossref]

14. Patra, S., Shome, A., Patra, C. C., & Mahto, S. K. (2025). Patra index and Mentzer index–A retrospective comparative study to differentiate Beta-Thalassemia Trait from iron deficiency anemia. Journal of Family Medicine and Primary Care, 14(11), 4568-4573. [Google Scholar] [Crossref]

15. Bajwa H, Basit H. Thalassemia. StatPearls. Publishing.2024 [Google Scholar] [Crossref]

16. Galanello, R., & Origa, R. (2012). Beta-thalassemia: orphanet j rare dis. Journal of Continuing Education Topics & Issues, 14(1), 33-34. [Google Scholar] [Crossref]

17. Maden, A. A., Hortu, H. Ö., Üzüm, Ö., Eliaçık, K., Kanık, A., Malbora, B., ... & Helvacı, M. (2020). Beta Talasemi minör tanılı ergenlerde anksiyete ve depresyon düzeylerinin değerlendirilmesi. İzmir Katip Çelebi Üniversitesi Sağlık Bilimleri Fakültesi Dergisi, 5(3), 277-280. [Google Scholar] [Crossref]

18. Bahar, A., Kashi, Z., Sohrab, M., Kosaryan, M., & Janbabai, G. (2012). Relationship between beta-globin gene carrier state and insulin resistance. Journal of Diabetes & Metabolic Disorders, 11(1), 22. [Google Scholar] [Crossref]

19. Kabasakal, E., Ergene, Ü., & Özlü, C. (2018). Normal complete blood count reference intervals in the Turkish population: a prospective study. Hematol Transfus Int J, 6(4), 135-139. [Google Scholar] [Crossref]

20. Hossain, M. S., Islam, F., Akhter, S., & Al Mossabbir, A. (2025). Thalassemia in Bangladesh: progress, challenges, and a strategic blueprint for prevention. Orphanet Journal of Rare Diseases, 20(1), 358. [Google Scholar] [Crossref]

21. BBS. National Thalassemia Survey 2024 [Internet]. angladesh Bureau of Statistics (BBS).2024 Jul. [Google Scholar] [Crossref]

22. Sultana, G. N. N., Begum, R., Akhter, H., Shamim, Z., Rahim, M. A., & Chubey, G. (2016). The complete spectrum of beta (β) thalassemia mutations in Bangladeshi population. Austin Biomark Diagn, 3(1), 1024. [Google Scholar] [Crossref]

23. Merdin, A. (2018). Suggestion of new formulae to be used in distinguishing beta thalasemia trait from iron deficiency anemia. Acta Med Mediter, 34, 393-395. [Google Scholar] [Crossref]

24. Uddin, M. M., Akteruzzaman, S., Rahman, T., Hasan, A. M., & Shekhar, H. U. (2012). Pattern of β‐thalassemia and other haemoglobinopathies: A cross‐sectional study in Bangladesh. International Scholarly Research Notices, 2012(1), 659191. [Google Scholar] [Crossref]

25. Camaschella, C. (2015). Iron-deficiency anemia. New England journal of medicine, 372(19), 1832-1843. [Google Scholar] [Crossref]

26. Amooee, S., Samsami, A., Jahanbakhsh, J., & Karimi, M. (2011). The pregnancy outcome in patients with minor β-thalassemia. Iranian journal of reproductive medicine, 9(1), 9. [Google Scholar] [Crossref]

27. Luewan, S., Srisupundit, K., & Tongsong, T. (2009). Outcomes of pregnancies complicated by beta-thalassemia/hemoglobin E disease. International Journal of Gynecology & Obstetrics, 104(3), 203-205. [Google Scholar] [Crossref]

28. Charoenboon, C., Jatavan, P., Traisrisilp, K., & Tongsong, T. (2016). Pregnancy outcomes among women with beta-thalassemia trait. Archives of gynecology and obstetrics, 293(4), 771-774. [Google Scholar] [Crossref]

29. Xiong, X., Buekens, P., Alexander, S., Demianczuk, N., & Wollast, E. (2000). Anemia during pregnancy and birth outcome: a meta-analysis. American journal of perinatology, 17(03), 137-146. [Google Scholar] [Crossref]

30. Figueiredo, A. C., Gomes-Filho, I. S., Silva, R. B., Pereira, P. P., Mata, F. A. D., Lyrio, A. O., ... & Pereira, M. G. (2018). Maternal anemia and low birth weight: a systematic review and meta-analysis. Nutrients, 10(5), 601. [Google Scholar] [Crossref]

Metrics

Views & Downloads

Similar Articles